Dr. Rakesh Mishra, Director, Tata Institute for Genetics and Society, India speaks to The Hindu on the COVID-19 pandemic, vaccines, variants and steps we need to take in order to ensure maximum safety, without hampering the economy.
16Feb
Related Posts
14Dec
Molecular Geneticist Interview – Dr. Anirudha Lakshminarasimhan
A career in research is all about encountering many challenges and troubleshooting... read more
06Jul
The pursuit of a cure for hemophilia – Vasanth Thamodaran
History books, from as early as 2nd century AD, indicate knowledge of a... read more
30Jan
Agricultural biotechnology: Gene editing versus gene modification, The Indian Express, 30 Jan 2020
29May
Quick sequencing offers a better chance at COVID control
The SARS-CoV-2 virus has an opportunity to change every time it replicates... read more
30Jun
The impact of Next Generation Sequencing on human health and agriculture
Next-Generation Sequencing (NGS) denotes high-throughput sequencing in a massively parallel fashion that... read more
28Jul
Wastewater surveillance reveals infection dynamics
Dr. Farah Ishtiaq, Principal scientist at Tata Institute for Genetics and Society... read more
04May
COVID-19 is airborne; Masks still essential to avoid the spread of virus, Collaborative Study reveals
In a collaborative study, it is found that, novel Coronavirus is airborne... read more
28Apr
Impact of Covid ‘is down but not out’, do not be careless: Health experts
In an exclusive interview to ANI, the Director of Tata Institute for... read more
22Aug
Wastewater surveillance advocated for COVID tracking
More municipal corporations across the country are now willing to participate in... read more